Andera Partners

Primary contact
2, place Rio de Janeiro
75008 Paris
France
+33 1 85 73 64 00
2, place Rio de Janeiro
75008 Paris
France
+33 1 85 73 64 00
Key people ๐งโ๐คโ๐ง
- Vanessa Favier-Klak - COO
- Andrei Buzdugan - CFO
- Raymond W. Cohen - Andera Life Sciences' Venture Advisor
- Thierry Hercend - Andera Life Sciences' Venture Partner
- Loan Hoang-Sayag - Andera Life Sciences' Venture Partner
- Jan Van den Bossche - Andera Life Sciences' Partner
- Raphaรซl Wisniewski - Andera Life Sciences' Partner
- Sofia Ioannidou - Andera Life Sciences' Partner
- Gilles Nobรฉcourt - Andera Life Sciences' Partner
- Olivier Litzka - Andera Life Sciences' Partner
Investments ๐ธ
AgomAb Therapeutics
Developer of growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues
๐ Ghent, Belgium
Developer of growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues
๐ Ghent, Belgium
AM-Pharma
A biopharmaceutical company developing alkaline phosphatase (AP) as a treatment for severe inflammatory diseases
๐ Utrecht, Netherlands
A biopharmaceutical company developing alkaline phosphatase (AP) as a treatment for severe inflammatory diseases
๐ Utrecht, Netherlands
Artios Pharma
Developer of cancer treatments that target DNA Damage Response pathways to selectively kill cancer cells
๐ Cambridge, United Kingdom
Developer of cancer treatments that target DNA Damage Response pathways to selectively kill cancer cells
๐ Cambridge, United Kingdom
Medical Microinstruments
Developer of a robotic system that enables surgeons to achieve better outcomes in microsurgery
๐ Pisa, Italy
Developer of a robotic system that enables surgeons to achieve better outcomes in microsurgery
๐ Pisa, Italy
MedLumics
Developer of a radiofrequency cardiac ablation catheter that allows the treatment of atrial fibrillation in real time
๐ Madrid, Spain
Developer of a radiofrequency cardiac ablation catheter that allows the treatment of atrial fibrillation in real time
๐ Madrid, Spain
TriCares
Developer of a a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation
๐ Paris, France
Developer of a a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation
๐ Paris, France
Last update:
September 14, 2022
Disclaimer: The content on this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances.